Vitamin B12 absorption after allogeneic bone marrow transplantation.
- 1 December 1987
- journal article
- research article
- Published by BMJ in Journal of Clinical Pathology
- Vol. 40 (12) , 1472-1474
- https://doi.org/10.1136/jcp.40.12.1472
Abstract
The B12 absorption test (Schilling test) with intrinsic factor was used to examine ileal B12 absorption in 26 patients after allogeneic transplantation. The test was well tolerated and showed a profound fall in B12 absorption, which was maximal at two weeks after transplantation and recovered by eight weeks. The predominant influence on absorption at this stage was probably the conditioning schedule, and the presence of acute graft versus host disease (GVHD) was not associated with a further impairment of absorption. Six patients with chronic GVHD were studied. When compared with nine patients without GVHD there was a significant (p < 0.005) reduction of B12 absorption. These findings suggest that the B12 absorption test may be a useful non-invasive method of studying bowel function after bone marrow transplantation.This publication has 9 references indexed in Scilit:
- Absorption of oral aminoglycosides following bone marrow transplantationCancer, 1984
- Infectious Gastroenteritis in Bone-Marrow-Transplant RecipientsNew England Journal of Medicine, 1982
- Esophageal abnormalities in chronic graft-versus-host disease in humansGastroenterology, 1981
- Gastrointestinal radiographic features of human graft-vs.-host diseaseAmerican Journal of Roentgenology, 1981
- The diagnostic accuracy of the rectal biopsy in acute graft-versus-host disease: A prospective study of thirteen patientsGastroenterology, 1980
- Gastrointestinal graft-versus-host disease in manThe American Journal of Surgical Pathology, 1979
- CLINICAL MANIFESTATIONS OF GRAFT-VERSUS-HOST DISEASE IN HUMAN RECIPIENTS OF MARROW FROM HL-A-MATCHED SIBLING DONOR,STransplantation, 1974